GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Zhejiang Shengda Bio-Pharm Co Ltd (SHSE:603079) » Definitions » Research & Development

Zhejiang Shengda Bio-Pharm Co (SHSE:603079) Research & Development : ¥41.6 Mil (TTM As of Mar. 2024)


View and export this data going back to 2017. Start your Free Trial

What is Zhejiang Shengda Bio-Pharm Co Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. Zhejiang Shengda Bio-Pharm Co's Research & Development for the three months ended in Mar. 2024 was ¥7.9 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2024 was ¥41.6 Mil.


Zhejiang Shengda Bio-Pharm Co Research & Development Historical Data

The historical data trend for Zhejiang Shengda Bio-Pharm Co's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zhejiang Shengda Bio-Pharm Co Research & Development Chart

Zhejiang Shengda Bio-Pharm Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 27.90 35.69 39.64 37.42 42.93

Zhejiang Shengda Bio-Pharm Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 9.19 12.02 8.97 12.74 7.90

Zhejiang Shengda Bio-Pharm Co Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥41.6 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Zhejiang Shengda Bio-Pharm Co  (SHSE:603079) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.


Zhejiang Shengda Bio-Pharm Co Research & Development Related Terms

Thank you for viewing the detailed overview of Zhejiang Shengda Bio-Pharm Co's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.


Zhejiang Shengda Bio-Pharm Co (SHSE:603079) Business Description

Traded in Other Exchanges
N/A
Address
No.789, Renmin East Road, Chicheng Street, Tiantai County, Zhejiang Province, Hangzhou, CHN, 317200
Zhejiang Shengda Bio-Pharm Co Ltd is a pharmaceutical company. It is mainly engaged in the research and development, and production of biotin and biological preservatives. Its product portfolio includes biotin, folic acid and other vitamin products, as well as nisin and natamycin.

Zhejiang Shengda Bio-Pharm Co (SHSE:603079) Headlines

No Headlines